Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines
Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.
Source: news-medical.net
Stay updated with breaking news from Omicrons Based. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.
In a recent study posted to the bioRxiv* preprint server, researchers investigated the mutation in the viral spike (S) protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 variant (referred to as Omicron in the present study) that is responsible for the variant’s virological features.
Researchers developed a vaccine candidate termed Ad26.COV2.S.529, encoding a stabilized Omicron-based S protein resembling ancestral SARS-CoV-2 Wuhan-Hu-1 S protein.